T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
PRHSX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 1, 2015 at 4pm EST
Fund Composition
Asset Allocation
as of 03/31/2015
Domestic Stock 85.9%
Foreign Stock 8.6%
Cash 5.3%
Convertibles 0.4%
Foreign Bonds 0.0%
Preferreds 0.0%
Options -0.1%
Volatility and Other Measures
as of 05/31/2015
Beta 0.90
0.32
Standard Deviation 13.34
Price/Earnings Ratio (Domestic) 22.1
Earnings Growth Rate (Domestic) 13.8
Turnover Rate 14
Median Market
Capitalization
$32,698.66 Million
10 Largest Holdings
Represents 32.57 % of Total Net Assets
View Holdings as of:
AbbVie
Aetna
Alexion Pharmaceuticals
Allergan
Gilead Sciences
Humana
Incyte
McKesson
UnitedHealth Group
Valeant Pharmaceuticals International
As of 05/31/2015 the Health Sciences Fund had a total of 159 holdings.
Sector Diversification
as of 05/31/2015
% of Total Net Assets
Biotechnology 32.0%
Services 27.5%
Pharmaceuticals 19.6%
Products & Devices 9.6%
Life Sciences 4.6%
See Glossary for additional details on all data elements.